Rose Cuneo
Primary Care · Houma, LANPI 1083010318
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 12.7% — the pattern of someone who eats at a lot of different presentations.
Across 114 payments — averaging $27.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$394
- Vanda Pharmaceuticals Inc.$348
- AbbVie$278
- Neurocrine Biosciences, Inc.$271
- Alkermes, Inc.$221
- Novo Nordisk$218
- plus $1K from 16 others
What the payments were for
- Food & beverage$2,99697%
- Education$993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $394 |
| Vanda Pharmaceuticals Inc. | 13 | $348 |
| AbbVie | 15 | $278 |
| Neurocrine Biosciences, Inc. | 11 | $271 |
| Alkermes, Inc. | 8 | $221 |
| Novo Nordisk | 2 | $218 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $200 |
| Teva Pharmaceuticals USA, Inc. | 11 | $166 |
| Lilly USA, LLC | 2 | $115 |
| GSK | 5 | $109 |
| Amgen | 1 | $103 |
| Lundbeck LLC | 7 | $101 |
| Astellas Pharma US Inc | 1 | $99 |
| Boehringer Ingelheim | 1 | $96 |
| Johnson & Johnson | 4 | $87 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| Gilead | 4 | $67 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Viiv Healthcare Company | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Merck | 1 | $22 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,095 in reported general payments places this provider in the 85th percentile of 106 primary care providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 67 | $82,329 |
| OzempicSemaglutide | 52 | $49,494 |
| FarxigaDapagliflozin Propanediol | 36 | $31,870 |
| TrulicityDulaglutide | 26 | $24,355 |
| JardianceEmpagliflozin | 16 | $13,370 |
| EntrestoSacubitril/Valsartan | 13 | $9,597 |
| EliquisApixaban | 13 | $9,559 |
| JanuviaSitagliptin Phosphate | 11 | $7,089 |
| DapagliflozinDapagliflozin Propanediol | 12 | $6,535 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 59 | $1,399 |
| Metformin Er GastricMetformin Hcl | 11 | $1,260 |
| Metformin Hcl | 42 | $971 |
| Atorvastatin Calcium | 114 | $970 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 11 | $703 |
| Azelastine Hcl | 12 | $560 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $115 | $106,68493 claims |
| Novo NordiskOzempic | $218 | $49,49452 claims |
| AstraZenecaFarxiga | $394 | $31,87036 claims |
| Boehringer IngelheimJardiance | $96 | $13,37016 claims |
| MerckJanuvia | $22 | $7,08911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 106 primary care providers in Louisiana.
Other primary care in Houma
- Eleisa FloydHouma$6K
- Jennifer MilletHouma$3K
- Jennifer VillalobosHouma$2K
- Jill BuecheHouma$1K
- Wendy TaylorShreveport$15K
- Jodi BurasCovington$14K
- Mia Schexnayder-DavisNew Orleans$10K
- Lourdes TorresMonroe$8K
- Danielle WebsterPrairieville$8K
- Alle NorrisCovington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.